pharmaceutical firm

The US has imposed visa restrictions on 13 individuals, including the owner of an Indian online pharmacy, KS International Traders, accused of selling illicit fentanyl-laced drugs to Americans. This action follows previous sanctions against Indian nationals and firms involved in trafficking fentanyl and its precursor chemicals, highlighting a joint effort between the US and India to combat drug networks.

Seeks Singapore Tie-Up for Growth of Capital City

Indian companies are significantly boosting the US economy with substantial investments, creating thousands of jobs, and driving innovation. Senior officials highlighted nearly $16.4 billion in cumulative FDI, supporting over 70,000 jobs and significant R&D. Further commitments are anticipated, underscoring India's growing role in key American sectors.

Modern research reveals that rose petals offer more than just a calming scent for the skin. Compounds within roses exhibit antioxidant and anti-inflammatory properties, potentially protecting collagen and elastin from breakdown. While not a magical cure, these natural ingredients gently support skin health by combating free radical damage and reducing irritation.

Indian companies are set to invest over $20.5 billion dollars in the United States in various sectors including technology, manufacturing, and pharmaceuticals. "Twelve Indian firms alone announced 1.1 billion dollars in new investments today and these partnerships are creating American jobs and strengthening supply chains," US ambassador to India Sergio Gor said.

Indian students are shifting their overseas education focus from traditional destinations like the US and UK to emerging European and Asian countries. Driven by industry relevance, affordability, and specialized courses, Germany, France, Japan, and South Korea are gaining popularity for their strong career pathways and technological advancements.

Lower-cost, latest-generation immunotherapies from China are a shot in the arm for Indian cancer patients who have been priced out of treatment by expensive drugs from western MNCs

Bees are vital pollinators, crucial for global food security and ecosystems, yet face severe threats from climate change, pesticides, and habitat loss. Their declining populations, particularly in India, signal a critical ecological crisis. Urgent action is needed from farmers and citizens to protect these essential insects.

Indian pharmaceutical giant Sun Pharma is set to acquire US-based Organon & Co. for $11.75 billion in an all-cash deal. This landmark acquisition, one of India's largest overseas ventures, will propel Sun Pharma into the top 25 global pharma companies. The move significantly bolsters its presence in women's health and biosimilars, expanding its global reach across 150 countries.

Good news for Indian patients as the Patent Office rejected AbbVie's Rinvoq patent, citing obviousness and lack of inventive step. This decision, crucial for affordable generic versions, prevents patent 'evergreening' and upholds India's patent law. Generic manufacturers had opposed the application, leading to extensive hearings. Rinvoq treats autoimmune diseases and has significant global sales.